Browsing by Author "Limoncu Baser, Hatice"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial(Elsevier, 2018-05) Özakbaş, Serkan; Türkoğlu, Recai; Tamam, Yusuf; Terzi, Murat; Yücesan, Canan; Limoncu Baser, Hatice; Gencer, Mehmet; Akıl, Eşref; Sen, Sedat; Yiğit, Pınar; Taşkapılıoğlu, Özlem; Turan, Ömer Faruk; Türkeş, Nevin; Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Beyin ve Sinir Hastalıkları Anabilim Dalı.; 0000-0003-4436-3797; AAK-6623-2020; JDI-6091-2023; EAD-0629-2022; 23037226400; 23037113500; 35886020700Background: Cognitive impairment (CI) is a common problem in multiple sclerosis (MS), may occur either in early or late phase of the disease, and impairs quality of life. Objectives: This study aimed to determine the prevalence of CI and related risk factors in relapsing-remitting MS (RRMS) patients in Turkey. Methods: The present cross-sectional, multi-center, and nationally representative study included RRMS patients. Sociodemographic characteristics, cognitive functions and additional outcomes were compared between patients with and without CI. Results: The analyses included 487 RRMS patients. According to the BRB-N battery results, CI prevalence was 53.7%. There was a negative significant correlation of BRB-N subtests with age, disease duration, and EDSS and MSNQ-patient rated scores. On the logistic regression analysis, increased age, living in village/rural area, high income level, and high EDSS score were significant increasing risk factors in the development of CI. Conclusions: This is the first national cognitive data obtained from MS in Turkey, which is a country between Europe and Asia and thus has characteristics of both continents. The similarity of the results of the present study obtained from Turkey to the Western-based data indicates that CI is universal in MS and the main factors affecting CI have not changed.